Institutional Ownership Athira Pharma, Inc. (ATHA)
This table provides information about the institutional ownership of Athira Pharma, Inc. (ATHA). We have compiled data on the 62 institutions that hold shares in the stock, with a total of 18.8 Million shares, which have been reported (via 13F filing form) to have a value of $6.94 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Perceptive Advisors LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
5,402,964
shares
|
$2 Million
0.11% of portfolio
|
Q4 2023
Added 12.63%
|
|
|
Bml Capital Management, LLC
Zionsville, IN |
Feb 06, 2025 Q4 2024 |
2,775,885
shares
|
$1.03 Million
1.01% of portfolio
|
Q4 2024
New holding
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
1,556,651
shares
|
$575,960
0.0% of portfolio
|
Q4 2024
Reduced 3.5%
|
|
|
Simplify Asset Management Inc.
New York, NY |
Feb 11, 2025 Q4 2024 |
1,492,792
shares
|
$552,333
0.05% of portfolio
|
Q2 2023
Added 7.38%
|
|
|
Propel Bio Management, LLC
Los Angeles, CA |
Feb 14, 2025 Q4 2024 |
1,492,792
shares
|
$552,333
0.87% of portfolio
|
Q4 2023
New holding
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
676,244
shares
|
$250,210
0.0% of portfolio
|
Q2 2024
Added 1.34%
|
|
|
Tang Capital Management LLC
San Diego, CA |
Feb 14, 2025 Q4 2024 |
600,000
shares
|
$222,000
0.03% of portfolio
|
Q3 2024
Reduced 43.0%
|
|
|
Acadian Asset Management LLC
Boston, MA |
Feb 11, 2025 Q4 2024 |
434,492
shares
|
$160,762
0.0% of portfolio
|
Q4 2024
Reduced 8.82%
|
|
|
Pathstone Family Office, LLC
Englewood, NJ |
Nov 08, 2023 Q3 2023 |
425,492
shares
|
$157,432
0.01% of portfolio
|
Q3 2022
Added 7.5%
|
|
|
Bank Of America Corp
Charlotte, NC |
Feb 14, 2025 Q4 2024 |
416,143
shares
|
$153,972
0.0% of portfolio
|
Q4 2024
Reduced 2.95%
|
|
|
Pathstone Holdings, LLC
Englewood, NJ |
Feb 14, 2025 Q4 2024 |
372,196
shares
|
$137,712
0.0% of portfolio
|
Q4 2024
Reduced 24.37%
|
|
|
Qube Research & Technologies LTD
London, X0 |
Feb 14, 2025 Q4 2024 |
350,007
shares
|
$129,502
0.0% of portfolio
|
Q4 2024
Added 455.28%
|
|
|
Bristlecone Advisors, LLC
|
Jan 29, 2025 Q4 2024 |
337,506
shares
|
$124,877
0.02% of portfolio
|
Q3 2024
Added 295.64%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
320,844
shares
|
$118,712
0.0% of portfolio
|
Q3 2024
Added 4.45%
|
|
|
Gsa Capital Partners LLP
London, X0 |
Feb 07, 2025 Q4 2024 |
296,556
shares
|
$109,725
0.01% of portfolio
|
Q4 2024
Reduced 25.32%
|
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
Feb 14, 2025 Q4 2024 |
253,300
shares
|
$93,721
0.0% of portfolio
|
Q4 2024
Reduced 24.97%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Feb 13, 2025 Q4 2024 |
207,300
shares
|
$76,701
0.0% of portfolio
|
Q4 2024
Reduced 54.22%
|
|
|
Royal Bank Of Canada
Toronto, A6 |
Feb 14, 2025 Q4 2024 |
183,018
shares
|
$67,716
0.0% of portfolio
|
Q4 2024
Added 2094.2%
|
|
|
Potomac Capital Management, Inc.
|
Feb 14, 2024 Q4 2023 |
149,585
shares
|
$55,346
0.64% of portfolio
|
Q4 2023
Added 100.56%
|
|
|
Laird Norton Trust Company, LLC
|
Feb 14, 2025 Q4 2024 |
127,309
shares
|
$47,104
0.01% of portfolio
|
Q4 2024
Reduced 13.58%
|
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
107,381
shares
|
$39,730
0.0% of portfolio
|
Q4 2024
Reduced 0.37%
|
|
|
Ubs Group Ag
|
Feb 14, 2025 Q4 2024 |
86,976
shares
|
$32,181
0.0% of portfolio
|
Q4 2024
Added 635.34%
|
|
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
Feb 07, 2025 Q4 2024 |
81,300
shares
|
$30,081
0.0% of portfolio
|
Q4 2024
Reduced 1.28%
|
|
|
Northern Trust Corp
Chicago, IL |
Feb 14, 2025 Q4 2024 |
53,609
shares
|
$19,835
0.0% of portfolio
|
Q2 2024
Added 0.73%
|
|
|
Clarius Group, LLC
Seattle, WA |
Jan 15, 2025 Q4 2024 |
53,551
shares
|
$19,813
0.0% of portfolio
|
Q4 2023
Added 35.82%
|